156 related articles for article (PubMed ID: 18613758)
1. Combining stem cells and exon skipping strategy to treat muscular dystrophy.
Meregalli M; Farini A; Torrente Y
Expert Opin Biol Ther; 2008 Aug; 8(8):1051-61. PubMed ID: 18613758
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
Rodrigues M; Yokota T
Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
5. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches to muscular dystrophy.
Goyenvalle A; Seto JT; Davies KE; Chamberlain J
Hum Mol Genet; 2011 Apr; 20(R1):R69-78. PubMed ID: 21436158
[TBL] [Abstract][Full Text] [Related]
7. Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy.
Matsuo M
Brain Dev; 1996; 18(3):167-72. PubMed ID: 8836495
[TBL] [Abstract][Full Text] [Related]
8. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
[TBL] [Abstract][Full Text] [Related]
9. Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy.
Wilton SD; Fletcher S
Curr Pharm Des; 2010; 16(8):988-1001. PubMed ID: 20041827
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Japanese patients to development of antisense therapy for DMD.
Matsuo M; Takeshima Y; Nishio H
Brain Dev; 2016 Jan; 38(1):4-9. PubMed ID: 26094594
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
[TBL] [Abstract][Full Text] [Related]
12. Emerging strategies for cell and gene therapy of the muscular dystrophies.
Muir LA; Chamberlain JS
Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
[TBL] [Abstract][Full Text] [Related]
13. Designing Effective Antisense Oligonucleotides for Exon Skipping.
Shimo T; Maruyama R; Yokota T
Methods Mol Biol; 2018; 1687():143-155. PubMed ID: 29067661
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in large animal models of muscular dystrophy.
Wang Z; Chamberlain JS; Tapscott SJ; Storb R
ILAR J; 2009; 50(2):187-98. PubMed ID: 19293461
[TBL] [Abstract][Full Text] [Related]
15. Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.
Nakamura A
J Hum Genet; 2017 Oct; 62(10):871-876. PubMed ID: 28566768
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for muscular dystrophy: current progress and future prospects.
Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
[TBL] [Abstract][Full Text] [Related]
17. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T
Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
Maruyama R; Aoki Y; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
[TBL] [Abstract][Full Text] [Related]
19. Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.
Yokota T; Pistilli E; Duddy W; Nagaraju K
Expert Opin Biol Ther; 2007 Jun; 7(6):831-42. PubMed ID: 17555369
[TBL] [Abstract][Full Text] [Related]
20. [Development of an ultrasound-mediated nucleic acid delivery system for treating muscular dystrophies].
Negishi Y; Hamano N; Shiono H; Akiyama S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Yakugaku Zasshi; 2012; 132(12):1383-8. PubMed ID: 23208045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
